Drugs - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Drugs industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Drugs - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Drugs
Corporate Insider Buy Sell Ratio (Insider Count) - Drugs
Drugs - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-03 PULM / Pulmatrix, Inc. 4 Higgins Michael J A - Award D 8,800
2025-12-09 RZLT / Rezolute, Inc. 4 Evans Daron P - Purchase D 5.04 10,549
2025-09-19 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.79 -3,656
2025-09-19 UTHR / United Therapeutics Corporation 4 Olian Judy D. S - Sale D 415.4266 -1,800
2025-09-19 PGEN / Precigen, Inc. 4 KIRK RANDAL J by Kapital Joe S - Sale I 3.68 -3,596,892
2025-09-19 ELVN / Enliven Therapeutics, Inc. 4 Kintz Samuel S - Sale I 20.25 -1,000
2025-09-19 APLS / Apellis Pharmaceuticals, Inc. 4 Dunlop A. Sinclair Indirect Owner (Epidarex) S - Sale I 22.95 -31,092
2025-09-19 ACLX / Arcellx, Inc. 4 Heery Christopher S - Sale D 80 -300
2025-09-19 APLS / Apellis Pharmaceuticals, Inc. 4 Dunlop A. Sinclair Indirect Owner (Epidarex) J - Other I -3,837
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 408.1142 -1,200
2025-09-18 PGEN / Precigen, Inc. 4 KIRK RANDAL J by Kapital Joe S - Sale I 3.86 -1,403,360
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 763.292 -39,863
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 404.3275 -1,100
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 767.065 -3,914
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 405.1961 -1,121
2025-09-18 RARE / Ultragenyx Pharmaceutical Inc. 4 Huizenga Theodore Alan S - Sale D 29.17 -64
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 405.4502 -2,973
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 406.3918 -3,222
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 406.0356 -879
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 403.2675 -2,000
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 766.451 -13,135
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 402.50 -400
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 764.519 -23,067
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 407.4171 -2,105
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 765.567 -26,647
2025-09-18 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.74 -5,307
2025-09-18 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4673 -20,870
2025-09-18 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale D 8.33 -10,000
2025-09-18 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4418 -366,111
2025-09-18 ACLX / Arcellx, Inc. 4 Heery Christopher S - Sale D 80.0085 -3,343
2025-09-18 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.4418 -228,791
2025-09-18 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale I 8.32 -3,086
2025-09-18 ROIV / Roivant Sciences Ltd. 4 Gline Matthew P - Purchase D 15.07 3,315
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A M - Exercise D 135.42 11,000
2025-09-18 CCCC / C4 Therapeutics, Inc. 4 Adams Kendra M - Exercise D 6,250
2025-09-18 CCCC / C4 Therapeutics, Inc. 4 Adams Kendra F - Taxes D 3.32 -2,775
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4535 -2,121
2025-09-17 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.83 -2,304
2025-09-17 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.4892 -226,726
2025-09-17 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4892 -362,806
2025-09-17 KYMR / Kymera Therapeutics, Inc. 4 Jacobs Bruce N. S - Sale D 50.0048 -79,220
2025-09-17 ELVN / Enliven Therapeutics, Inc. 4 Kintz Samuel S - Sale I 19.0946 -5,000
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Koenig Sheldon L. S - Sale D 2.788 -28,427
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Halladay Benjamin S - Sale D 2.808 -7,046
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Looker Benjamin S - Sale D 2.804 -6,267
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.9702 -3,135
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 400.9021 -865
2025-09-17 AWHL / Aspira Women's Health Inc. 4 SCHULER JACK W By Jack W. Schuler Living Trust P - Purchase I 0.45 1,111,111
2025-09-17 AWHL / Aspira Women's Health Inc. 4 cohen Jeffrey k By HealthView Asset Management P - Purchase I 0.45 55,556
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)